List of Excipients in API docetaxel
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing docetaxel
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sanofi-Aventis US LLC | TAXOTERE | docetaxel | 0075-8003 | ALCOHOL | |
| Sanofi-Aventis US LLC | TAXOTERE | docetaxel | 0075-8003 | POLYSORBATE 80 | |
| Hospira Inc | DOCETAXEL | docetaxel | 0409-0366 | ALCOHOL | |
| Hospira Inc | DOCETAXEL | docetaxel | 0409-0366 | CITRIC ACID MONOHYDRATE | |
| Hospira Inc | DOCETAXEL | docetaxel | 0409-0366 | POLYSORBATE 80 | |
| Hospira Inc | DOCETAXEL | docetaxel | 0409-4235 | ALCOHOL | |
| Hospira Inc | DOCETAXEL | docetaxel | 0409-4235 | CITRIC ACID MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing docetaxel
Detailed excipient profiles for docetaxel
Excipient focus: ALCOHOL
docetaxel drug variants containing ALCOHOL
docetaxel drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | docetaxel | 23155-903 |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | docetaxel | 57884-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
docetaxel drug variants containing ANHYDROUS CITRIC ACID
docetaxel drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
docetaxel drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Avyxa Pharma LLC | docetaxel | 83831-101 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
Excipient focus: CITRIC ACID MONOHYDRATE
docetaxel drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | docetaxel | 0409-0366 |
| Hospira Inc | docetaxel | 0409-4235 |
| Baxter Healthcare Corporation | docetaxel | 43066-001 |
| Sandoz Inc | docetaxel | 66758-050 |
| Sandoz Inc | docetaxel | 66758-950 |
| Hospira Inc | docetaxel anhydrous | 0409-0201 |
| Hospira Inc | docetaxel anhydrous | 0409-2026 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: DEHYDRATED ALCOHOL
docetaxel drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | docetaxel | 23155-903 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing DEHYDRATED ALCOHOL
Excipient focus: POLYETHYLENE GLYCOL 300
docetaxel drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | docetaxel | 43066-001 |
| Alembic Pharmaceuticals Limited | docetaxel | 46708-678 |
| Eugia US LLC | docetaxel | 55150-378 |
| Alembic Pharmaceuticals Inc | docetaxel | 62332-678 |
| Sandoz Inc | docetaxel | 66758-050 |
| Sandoz Inc | docetaxel | 66758-950 |
| Gland Pharma Limited | docetaxel | 68083-399 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing POLYETHYLENE GLYCOL 300
Excipient focus: POLYSORBATE 80
docetaxel drug variants containing POLYSORBATE 80
docetaxel drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co Ltd | docetaxel | 57884-3041 |
| Avyxa Pharma LLC | docetaxel | 83831-101 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
docetaxel drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Avyxa Pharma LLC | docetaxel | 83831-101 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing POVIDONE
Excipient focus: POVIDONE K12
docetaxel drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | docetaxel | 45963-734 |
| >Company | >Ingredient | >NDC |
docetaxel drug variants not containing POVIDONE K12
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
